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Acetic acidIn order to investigate whether and how amodiﬁcation of mitochondrial metabolism can affect yeast sensitivity
to programmed cell death (PCD) induced by acetic acid (AA-PCD), yeast cells were grown on rafﬁnose, as a sole
carbon source, which, differently from glucose, favours mitochondrial respiration. We found that, differently
from glucose-grown cells, rafﬁnose-grown cells were mostly resistant to AA-PCD and that this was due to the
activation of mitochondrial retrograde (RTG) response, which increased with time, as revealed by the up-
regulation of the peroxisomal isoform of citrate synthase and isocitrate dehydrogenase isoform 1, RTG pathway
target genes. Accordingly, the deletion of RTG2 and RTG3, a positive regulator and a transcription factor of the RTG
pathway, resulted in AA-PCD, as shown by TUNEL assay. Neither deletion in rafﬁnose-grown cells of HAP4,
encoding the positive regulatory subunit of the Hap2,3,4,5 complex nor constitutive activation of the RTG pathway
in glucose-grown cells due to deletion ofMKS1, a negative regulator of RTG pathway, had effect on yeast AA-PCD.
The RTG pathway was found to be activated in yeast cells containing mitochondria, in which membrane potential
wasmeasured, capable to consume oxygen in amanner stimulated by the uncoupler CCCP and inhibited by the re-
spiratory chain inhibitor antimycin A. AA-PCD resistance in rafﬁnose-grown cells occurs with a decrease in both
ROS production and cytochrome c release as compared to glucose-grown cells en route to AA-PCD.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Cell homeostasis depends on a complex signal transduction network
regulating cell capability to adapt or succumb to environmental stress in
which different cell components are involved; in this regard besides
being cell powerhouse, mitochondria are central organelles in the inte-
gration of intracellular signalling pathways and play a pivotal role in the
regulation of programmed cell death (PCD) [1–3]. Since signal transduc-
tion components andmechanisms are highly conserved among eukary-
otes, the unicellular yeast Saccharomyces cerevisiae is a suitable model
organism to study this issue. In fact, yeast undergoes a PCD process
which shares a variety of features withmammalian apoptosis including-chlorophenylhydrazone; cyt c,
cose-grown; H2DCH-DA, 2,7-
e; PCD, programmed cell death;
ethylrhodamine methyl ester;
iated dUTP nick end labelling;
e e Bioenergetica, Via Amendola
0805443317.
asio).
ights reserved.oxidative stress and the release of pro-apoptotic proteins, including cy-
tochrome c (cyt c), with attendant late mitochondrial dysfunction [4,5].
With amodel system inwhich PCDof yeast grown on glucose is induced
by acetic acid (AA-PCD), the time course of key events which take place
en route to PCD, including ROS production, cyt c release and mitochon-
drial dysfunction, was described in some detail [5–7]. It was also shown
that AA-PCD can also occur in cells lacking cyt c and/or the yeast
metacaspase YCA1 via a N-acetyl cysteine (NAC)-insensitive death
pathway [8–10]. Although AA-PCD has already been investigated in de-
tail, to datewhether and how the cellular energymetabolism can some-
how inﬂuence the occurrence of either AA-PCD pathways remains to be
established.
Glucose is a fermentable carbon source responsible for the down-
regulation of respiration [11,12], while rafﬁnose is a poorly fermentable
carbon source in which respiration is de-repressed [13]. Here we inves-
tigated yeast cell sensitivity to AA-PCD in yeast cells grown either in glu-
cose (GLU-WT cells) or in rafﬁnose (RAF-WT cells). We found that,
when rafﬁnose is used as a sole carbon source, differently fromwhat oc-
curs in glucose-grown cells, yeast cells become resistant to AA-PCD in a
mannermostly dependent on the retrograde (RTG)-pathway activation.
In this regard, that yeast dysfunctional mitochondria can communicate
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ascertained in the Butow's laboratory: the expression of a broad array
of nuclear target genes was ﬁrst demonstrated to be largely increased
in cells grown on rafﬁnose with impaired mitochondria including those
lacking mitochondrial DNA (ρ°) [14,15]. Yeast RTG signalling pathway
has been characterized in details [16,17] and its activation was shown
to extend replicative life span in yeast [18,19], possibly providing a de-
fense mechanism by which cells can respond to mitochondrial stress
leading to mitochondria impairment [20–22]. Surprisingly enough we
ﬁrst found that RTG pathway is active in yeast cells in which mitochon-
dria are still coupled.
2. Materials and methods
2.1. Yeast strains, growth conditions and acetic acid treatment
The S. cerevisiae strains used in this study are listed in Table 1. Cells
were grown at 30 °C in YPD or YPR (1% yeast extract, 2% bactopeptone,
and 2% glucose or rafﬁnose, respectively). Acetic acid treatment was
carried out as described [23]. Brieﬂy, cells were grown at 26 °C up to
exponential phase (OD600 = 0.7–0.8) in YPD or YPR, resuspended
(107 cells/ml) in the same medium adjusted to pH 3.00 with HCl,
containing or not containing (control) 80 mMacetic acid and incubated
for different times at 26 °C. Cell viability was determined by measuring
colony forming units (cfu) after 2 days of growth onYPDplates at 30 °C.
2.2. TUNEL assay and intracellular ROS detection
DNA fragmentation was detected by TUNEL assay. Acetic acid-
treated and control cells (2x107) were harvested at 150 min. Brieﬂy,
cells were ﬁxed in 3.7 % formaldehyde solution in PBS, digested with
750 μg/ml zymoliase 20 T and incubated in permeabilization solu-
tion (0.1 % Triton-X100, 0.1 % sodium citrate) for 2 min on ice, and
then with 30 μl TUNEL reaction mixture (In Situ Cell Death Detection
kit, Fluorescein, Roche) for 1 hour at 37 °C. After incubation cells
were washed, resuspended in PBS and observed using a Leica TCS
SP5 confocal microscope. To detect intracellular H2O2 10 μg/ml 2,7-
dihydrodichloroﬂuorescein diacetate (H2DCF-DA; Molecular Probes)
dissolved in ethanol was added to cells either 30 min before or during
cell treatment with or without acetic acid. 2x107 acetic acid-treated or
control cells were harvested at 15 min and oxidation to the ﬂuorophore
dichloroﬂuorescein (DCF) was detected by confocal ﬂuorescence mi-
croscopy analysis.
2.3. Real-time polymerase chain reaction (PCR)
The mRNA levels of peroxisomal citrate synthase and isocitrate
dehydrogenase isoform 1 encoding gene (CIT2 and IDH1, respectively)
were determined in exponentially growing cells (OD600 = 0.7) and in
acetic acid-treated or control cells. 20 ml of cell suspensionwere centri-
fuged at 3000 ×g. Cell pellets were either stored at−80 °C or immedi-
ately used to extract total RNAwith the RNeasyMini Kit (Qiagen GmbH,
Hilden,Germany) throughmechanical disruptionof cellwallswith glassTable 1
Strains of Saccharomyces cerevisiae used in this study.
Strain (name) Genotype Reference/source
W303-1B (WT) MATα ade2 leu2 his3 trp1 ura3 ρ+ X.J. Chen's lab⁎
W303-1B (ρ°) MATα ade2 leu2 his3 trp1 ura3 ρ° This study
Δrtg2 W303-1B rtg2Δ::LEU2 This study
Δrtg3 W303-1B rtg3Δ::LEU2 This study
Δhap4 W303-1B hap4Δ::kanMX4 This study
Δhap4Δrtg2 W303-1B rtg2Δ::LEU2 hap4Δ::kanMX4 This study
Δmks1 W303-1B mks1Δ::kanMX4 This study
⁎ Department of Biochemistry and Molecular Biology, SUNY Upstate Medical
Universituy, Syracuse, NY, USA.beads by Tissue Lyser (Qiagen). 1 μg RNA (OD260/OD280 ≥ 1.9) reverse
transcriptionwas immediately performedusingQuantiTect Reverse Tran-
scription Kit (Qiagen) and cDNA directly used for real-time PCR analysis
or stored at−80 °C. Real-time PCR was carried out by QuantiTect SYBR
Green PCR Kit (Qiagen) on an ABI Prism 7000 system using the following
primer pairs: for CIT2: (F) 5′-CGGTTATGGTCATGCTGTGCT-3′ and (R) 5′-
GGTCCATGGCAAACTTACGCT-3′; for IDH1: (F) TCGACAATGCCTCCATGCA
and (R) AAAGCAGCGCCAATGTTGC; for ACT1: (F) 5′-CTTTGGCTCCATC
TTCCATG-3′ and (R) 5′-CACCAATCCAGACGGAGTACTT-3′. The amount of
CIT2 and IDH1mRNAnormalizedwithACT1mRNAwas calculated in arbi-
trary units (a.u.) using the standard curve method.
2.4. Mitochondrial membrane potential and O2 consumption assay
Mitochondrial membrane potential was monitored essentially as in
[24]. Brieﬂy, cells (OD600 = 0.6) exponentially growing in YPD or YPR
were incubated with 500 nM tetramethylrhodamine methyl ester
(TMRM) (λex 540/λem590) (Life Technologies) for 45 min at 26 °C in
the dark and then resuspended (107 cells/ml) in the same medium ad-
justed to pH 3.00 with HCl, containing 500 nM TMRM. An aliquot was
also incubated with 20 μM CCCP for 15 min to collapse the membrane
potential. We conﬁrmed that 20 μMCCCP was not toxic, but can inhibit
the growth of WT cells on a non-fermentable carbon source. Cells
(about 5x105 cells/ml) were collected and resuspended in phosphate
buffer saline (PBS) and analyzed with a FACS Calibur (Becton Dickinson)
ﬂowcytometer. Monoparametric detection of ﬂuorescence was
performed using FL-2 and data were analyzed using WinMDI 2.9
software. Background ﬂuorescence without dye was analyzed in
both glucose and rafﬁnose and subtracted.
O2 consumption was continuously measured at 25 °C in a thermo-
statically controlled chamber equipped with a Clark oxygen electrode
(Oxygraf, Hansatech Instruments). In a typical experiment cell suspension
(1 x 107 cells/ml) inYPDor YPRmedium(ﬁnal volume equal to 1 ml)was
used. The oxygenuptake ratewasmeasured as a tangent at the initial part
of the progress curve and expressed as nmol O2 min−1 cell number−1.
Carbonyl cyanide m-chlorophenylhydrazone (CCCP) and antimycin A
(Sigma Aldrich) were dissolved in dimethyl sulphoxide and ethanol, re-
spectively; control wasmade that the solvents have no effect on the elec-
trode sensitivity.
2.5. Protein extraction and cell fractionation
Trichloroacetic acid (TCA) precipitation of total yeast cell pro-
teins was carried out as described by Dilova and Powers [25], with
some modiﬁcations. 5 ml of cell culture grown to exponential
phase (OD600 = 0.7) were harvested by centrifugation for 5 min
at 3900 rpm (Sepatech omnifuge 2.0 RS, Heraeus). Cells were lysed in
0.225 M NaOH/1 % 2-mercaptoethanol, 10 mM NaF, 1 mM Na3VO4 and
2 mM phenylmethylsulfonyl ﬂuoride and proteins were precipitated
with 6.1 % TCA. The protein pellet was then washed with 1 M Tris-HCl
(pH 6.8) and resuspended in SDS PAGE sample buffer (100 mM
Tris-HCl (pH 6.8), 4% SDS, 20% glycerol, 100 mM DTT, 0.002%
bromophenol blue). Cytosolic and mitochondrial fractions were isolat-
ed from 200 to 400 ml of acetic acid-treated or control cell culture as
described in [26]. Protein concentration was determined using the
Bradford assay [27].
2.6. Immunoblotting
To detect Rtg3p phosphorylation, equivalent amounts of total
cellular protein extracts were loaded on 7.5 % SDS-PAGE gels and
transferred to polyvinylideneﬂuoride (PVDF) membranes (Millipore,
Immobilon-P 0.4 μm) by semidry transfer units TE 70 (Amersham
Biosciences). Membranes were probed using polyclonal anti-Rtg3p
antibody and monoclonal anti-phosphoglycerate kinase (anti-Pgk1p)
antibody (Molecular Probes). Immunodetection was performed with
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ies using chemiluminescence Western blotting reagents (Amersham
ECL Western Blotting Detection Reagent, GE Healthcare Life Sciences).
To analyze cyt c release from mitochondria, either cytosolic or mi-
tochondrial fractions (10 μg of proteins) were loaded onto a 12%
SDS-polyacrylamide gel, separated and transferred to a PVDF mem-
brane which was probed with different antibodies: polyclonal anti-
cyt c, kindly provided by Fred Sherman (University of Rochester
Medical Center, Rochester, NY-USA), anti-Pgk1p and polyclonal
anti-acetohydroxyacidreductoisomerase (Ilv5p). Immunoblot anal-
ysis was performed with horseradish peroxidase-conjugated anti-
mouse or anti-rabbit antibodies using enhanced chemiluminescence
Western blotting reagents. Densitometric values for immunoreactive
bands were quantiﬁed using the Electrophoresis Documentation and
Analysis System 120 (Kodak). Protein levels were calculated as a
percentage of untreated cells taken as 100 in arbitrary units after
normalization based on the amount of Pgk1p or Ilv5p, for cytosolic
and mitochondrial fraction in each lane on the same ﬁlter.
3. Results
3.1. Yeast cells grown on rafﬁnose are resistant to AA-PCD induction and
show RTG pathway activation
In order to gain some insights into the role of mitochondrial metab-
olism on yeast cell sensitivity to AA-PCD we used either GLU-WT cells,
already used in AA-PCD investigations [23] or RAF-WT cells, in which
whether AA-PCD occurs has not been investigated to date. In the former
case a glycolytic energymetabolism occurs, in the latter energy produc-
tion results mostly from themitochondrial respiration [28,29]. Thus cell
viability was measured as a function of time after AA-treatment in
either GLU- or RAF-WT cells (Fig. 1). As in [23] GLU-WT cell viability
decreased along time and was zero 200 min after AA addition; this oc-
curred via AA-PCD as shown by 90% positive cells of TUNEL which is a
marker of PCD occurrence (Fig. 1A and B). Contrarily, the viability of
RAF-WT cells remained mostly constant with 80% viability at 200 minA
Fig. 1.W303-1B yeast cells are resistant to AA-PCD in an RTG2-dependantmanner. (A)WT (●)
(AA) in the presence of glucose (GLU) (dashed line) or rafﬁnose (RAF) (solid line) as the sole c
units (cfu). Cell survival (100%) corresponds to the cfu at time zero. Themeans of six independe
icantly differentwith (*) p b 0.005when comparingWT versusΔrtg2 cells in rafﬁnose. Death rat
of cfu as a function of time (see text). (B) DNA fragmentation was detected by using the TUNE
analyzed in three samples from each of three independent experiments. Student's t-test: statis
glucose (white bars) with AA-treated Δrtg2 and Δrtg3 cells in rafﬁnose (black bars) or AA-treaand with only about 10 % of DNA fragmentation at 150 min (Fig. 1A
and B).
To ﬁnd out how AA-PCD resistance occurs, in both cases we investi-
gated whether the RTG pathway was activated. Notice that it has been
reported previously that in glucose-grown cells, the RTG pathway is re-
pressed in respiratory-deﬁcient (ρ°) cells [19,30], whereas in rafﬁnose-
grown cells it is activated in response tomitochondrial dysfunction [31].
Thereforewe generated a variety ofmutants; one of themwas amutant
lacking RTG2 (RAF-Δrtg2) encoding a positive regulator of theRTGpath-
way which is known to regulate RTG3, encoding Rtg3p, a transcription
factor of the RTG pathway [32]. Since Rtg2p can also play a role in a
manner independent of Rtg3p, cells lacking RTG3 [32] grown in rafﬁ-
nose (RAF-Δrtg3) were also used.
Accordingly, both RAF-Δrtg2 and RAF-Δrtg3 cells were compared to
GLU-WT cells and, more importantly to RAF-WT cells with respect to
both cell viability and DNA fragmentation upon AA-treatment. In con-
trast to RAF-WT, both RAF-Δrtg2 and RAF-Δrtg3 cells showed a progres-
sive decline in cell viability, with viability lower than that of WT cells
already at 90 min, but 40 % viability was found at 200 min of AA-
treatment in both cases (Fig. 1A). The AA-PCD occurrence was shown
by a 6-fold increase of TUNEL positive cells (60 %) observedwith respect
to RAF-WT cells (Fig. 1B). Comparison made of the time course rates
showed a lower death rate for RAF-Δrtg2 and RAF-Δrtg3 cells with re-
spect to that of GLU-WT cells (0.0020 ± 0.0005 min−1 and 0.0020 ±
0.0001 min−1, respectively, versus 0.015 ± 0.002 min−1). This shows
that, when the RTG pathway was abolished due to RTG2/RTG3 deletion,
differently from WT, yeast cells even if grown on rafﬁnose can un-
dergo AA-PCD. In contrast, the route to AA-PCD of GLU-WT and
GLU-Δrtg2/Δrtg3 cells did not differ from one another (data not shown).
Since the change of the carbon source fromglucose to rafﬁnose results
in the activation of the Hap2,3,4,5 transcriptional complex [12,33] which
causes de-repression of a variety of mitochondrial proteins, including
components of the electron transport chain and citric acid cycle enzymes,
either RAF-WT or RAF-Δrtg2 cells lacking HAP4 were also used. Both
Δhap4 and Δrtg2Δhap4 cell viability in response to AA-treatment
did not differ along time from that of WT and Δrtg2 cells, respectivelyB
, Δrtg2 (■), Δartg3 (♦) Δhap4 (Δ) and Δrtg2Δhap4 (▲) cells were treated with acetic acid
arbon source. Cell viability was analyzed at indicated times by measuring colony-forming
nt experiments with standard deviations are reported. Student's t-test: statistically signif-
eswere calculated as the slope of the linear part of the semi-logarithmic plot of the number
L assay. Percentage of TUNEL positive cells is reported at 150 min. At least 400 cells were
tically signiﬁcantly different with (*) p b 0.0001 when comparing AA-treated WT cells in
ted WT cells in rafﬁnose.
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Fig. 2. The RTG pathway activation as a function of time after acid acetic treatment inWT andΔrtg2 cells. CIT2mRNA levels were measured by real-time PCR at the indicated times inWT
and Δrtg2 cells grown either in glucose (GLU) (white bars) or in rafﬁnose (RAF) (black bars) in the absence of acetic acid (C) or after acetic acid treatment (AA). E refers to cells before
starting the AA-treatment (for details see themethods). CIT2mRNA levels, normalized to that of ACT1mRNA, was reported in arbitrary units (a.u.). In the inset, relative RTG pathway ac-
tivation, calculated as the ratio between CIT2mRNA levels in acetic acid-treated and control RAF-WT cells, is plotted as a function of time.
Fig. 3. Rtg3p phosphorylation in WT and Δrtg2 cells treated with acetic acid in rafﬁnose.
Cell protein extracts were prepared from (A) RAF-WT and (B) RAF-Δrtg2 cells before
(E) and after acetic acid (AA) treatment at the indicated times and analyzed by immuno-
blot with anti-Rtg3p and anti-Pgk1p antibodies. Cell extracts from Δrtg3 cells have been
analyzed as a negative control.
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volved in AA-PCD resistance in RAF-WT cells.
To conﬁrm deﬁnitely that the RTG pathway activation is involved in
AA-PCD resistance in rafﬁnose-grown cells, we analyzed by real-time
PCR CIT2 mRNA expression, whose up-regulation is a marker of RTG
pathway activation [31]. This was made either in RAF-WT or GLU-WT
cells en route to AA-PCD (Fig. 2). As expected, in GLU-WT cells, no CIT2
up-regulation was found: CIT2 mRNA levels were low (≈2 a.u.) and
remained constant even after the shift to pH 3.00, and AA addition. In
contrast, in RAF-WT cells, the level of CIT2mRNA was found to increase
up to about 3-fold with respect to the basal level (similar to that in
GLU-WT cells) due to pH shift to 3.00 both in the absence and in the pres-
ence of AA-treatment, this showing that RTG pathway activation had oc-
curred. However, CIT2 expression in cells treated or not with acetic acid
proved to be signiﬁcantly different over time: cells shifted to pH 3.00
but without acetic acid addition, showed CIT2 level decreasing along
time up to a constant level in 90–200 min time range, whereas in
AA-treated cells CIT2mRNA levels remained relatively constant. No-
tice that the relative RTG pathway activation increased progressively
in AA RAF-WT cells which are AA-PCD resistant cells: the ratio of
CIT2 mRNA level between AA-treated and control cells at any times
increased along time up to about 2 and 3-fold in 60–200 min interval
(inset to Fig. 2). The expression of IDH1, another RTG-target gene
encoding for isocitrate dehydrogenase isoform 1 [34], was also mon-
itored, showing up-regulation of this gene after AA-treatment in
RAF-WT cells (not shown). This result conﬁrms deﬁnitely that AA-PCD
resistance is found in RAF-WT cells togetherwith a robust RTG pathway
activation. Accordingly, RTG2 deletion resulted in the lack of CIT2 ex-
pression in RAF-Δrtg2 cells (Fig. 2).
3.2. Rtg3p dephosphorylation correlates with AA-PCD resistance in
rafﬁnose-grown cells.
Further investigation of the involvement of RTG pathway in AA-PCD
resistance was made by monitoring the Rtg3p phosphorylation state. It
should be noted that both basal andup-regulated CIT2 transcription cor-
relates with the nuclear localization of the Rtg3p transcription factor[35]: in the cytosol it is usually in a hyper-phosphorylated state; an
Rtg2p-dependent partial dephosphorylation of Rtg3 results in its translo-
cation from the cytoplasm to the nucleus [31] with attendant activation
of RTG-target gene expression [25,35]. Thus we investigated whether
the Rtg3p phosphorylation state was affected in AA-treated cells grown
in rafﬁnose. Thiswasmade by immunoblottingwith anti-Rtg3p antibody,
being the hyper-phosphorylated state shown by the slowmobility of the
Rtg3p-immunoreactive band which is smeared likely due to multiple
phosphorylations. Equal loading of samples was conﬁrmed by probing
membranes with monoclonal anti-Pgk1p antibody, a cytosolic marker
protein. RAF-WT cells en route to AA-PCD showed increased mobility of
the Rtg3p immunoreactive band (Fig. 3, lanes A4–A9) with respect to
cells before AA-treatment (Fig. 3, lane A3), i.e. a continuous Rtg3p par-
tial dephosphorylation which correlates with the maximum AA-PCD
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Rtg3p hyper-phosphorylated state, as that measured in cells lacking
RTG2 (Fig. 3, lanes A2, B3–B9) which are partially resistant to AA-PCD
(see Fig. 1). As expected,we found that in AARAF-Δrtg2 cells Rtg3p phos-
phorylation state was constant. Since Rtg3p hyper-phosphorylation cor-
relates with RTG pathway inactivation, as detected by the lack of CIT2
expression (see Fig. 2), we propose that, based on data in Fig. 3, AA-PCD
resistance is not solely dependent on RTG2 capability to modulate Rtg3p
phosphorylation state, but RTG2 itself also play a role in AA-PCD resis-
tance independent of RTG3.
A deletionmutation inMKS1, encoding a negative regulator of theRTG
pathway, results in RTG pathway activation [25,36,37]. After establishing
that RTGpathway activation did not occur inGLU-WT cells,wedecided to
determine whether RTG pathway activation could itself make GLU-cells
resistant to AA-PCD. To that end, we investigated CIT2 expression,
cell viability and AA-PCD occurrence in GLU-WT and MKS1-knock-out
(GLU-Δmks1 cells) cells before and after AA-treatment. In any case, in
GLU-Δmks1 cells sustained CIT2 up-regulation was found with respect
to GLU-WT cells either with or without AA-treatment (Fig. 4A). Yet, de-
letion ofMKS1 failed to cause AA-PCD resistance: both the time course
of GLU-Δmks1 cell viability and the percentage of GLU-Δmks1 cells show-
ing DNA fragmentation were indistinguishable from the ones measured
inGLU-WTcells (Fig. 4C, D). RAF-Δmks1 resistance toAA-PCDwas similarA B
C
Fig. 4. The effect ofMKS1deletion on CIT2 expression andAA-PCD inW303-1B yeast cells grown in
Δmks1 cells grown either in 2% (A) or 0.5% (B) glucose (GLU), in the absence of acetic acid (C
AA-treatment. CIT2mRNA level, normalized to the level of ACT1mRNA, was reported in arbitrary
either 2% (solid lines) or 0.5% glucose (dashed lines) as carbon source. Cell viability was calculated
the cfu at time zero. The means of six independent experiments with standard deviations are rep
positive cells is reported at 150 min. At least 400 cells were analyzed in three samples from eachto that found in RAF-WT (not shown). Having established that MKS1-
dependent activation of RTG pathway does not result in AA-PCD resis-
tance in glucose-grown cells, we investigatedwhether glucose repression
was somehow involved in the failure of RTG activation in preventing
AA-PCD. To test this Δmks1 and WT cells were grown in 0.5 % glucose
(0.5 % GLU-Δmks1 and 0.5 % GLU-WT cells), where glucose repression
is not signiﬁcant, and analyzed as for CIT2 expression, cell viability and
DNA fragmentation after AA-treatment (Fig. 4). 0.5% GLU-WT cells
showed a moderate increase in their viability in 0–200 min range.
Such an AA-PCD resistance proved to be higher in 0.5%GLU-Δmks1
cells (Fig. 4C). Interestingly TUNEL test assay showed that only
20% 0.5%GLU-Δmks1 cells showed DNA fragmentation after AA-
treatment (Fig. 4D). RTG pathway was activated in 0.5%GLU-Δmks1
with respect to 0.5%GLU-WT cells, but at a lower level with respect to
GLU-Δmks1 cells (Fig. 4A, B). Such activation was found to remain con-
stant up to 200 min with or without AA-treatment as for GLU-Δmks1
cells.
3.3. Activation of RTG pathway due to cell shift to pH 3.00 takes place in
yeast containing coupled mitochondria
After establishing that in rafﬁnose-grown cells RTG pathway activa-
tion already occurs as a result shift to pH 3.00 along with previousD
glucose. CIT2mRNA levelsweremeasured by real-time PCR at the indicated times inWT and
) or after acetic acid treatment (AA). E refers to exponential phase cells before starting
units (a.u.). (C)WT (□) andΔmks1 (■) cells were treated with acetic acid in the presence of
at indicated times bymeasuring colony-forming units (cfu). 100% cell viability corresponds to
orted. (D) DNA fragmentation was detected by using the TUNEL assay. Percentage of TUNEL
of three independent experiments. WT, white bars; Δmks1, black bars; GLU, glucose.
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mitochondrial dysfunction [15,31], we investigatedwhether the change
in the carbon source and the shift to low pH could have impaired the
mitochondrial coupling. To this aim we ﬁrst resorted to a procedure
which allows for the detection of cells inwhichmitochondrialmembrane
potential was present. Thus we used the mitochondrial membrane
potential-sensitive probe TMRM which accumulates into polarized
mitochondria and equilibrate quickly [24,38,39]. The basic TMRM
ﬂuorescence of both RAF-WT and GLU-WT cells measured at pH 3.00
was largely decreased as a result of the addition of the uncoupler
CCCP (20 μM), showing the ΔΨ collapse (Fig. 5A). To conﬁrm that no
mitochondrial dysfunction barely takes place as a result of shift to
pH 3.00, we monitored the ability of mitochondria to take up oxygen
in amanner sensitive to the uncoupler CCCP. In an initial series of exper-
iments we monitored the continuous oxygen uptake by exponentially
growing (E) yeast cells incubated in their growthmedium and checked
whether the uncoupler CCCP could increase the rate of oxygen con-
sumption. As expected, due to their glycolytic metabolism, GLU-WT
cells can take up oxygen less effectively than RAF-WT cells can do. In a
typical experiment oxygen consumption rate was 3 versus 11 nmol
oxygen × min−1 × 107 cells−1 in E GLU-WT and E RAF-WT cells, respec-
tively (Fig. 5B). In E GLU-WT and E RAF-WT cells at neutral pH, 1.25 μM
CCCP addition also resulted in an increase of the oxygen consumption
rate from 3 and 11 up to 6 and 15 nmol oxygen × min−1 × 107 cells−1,
respectively. In any case 0.8 μM antimycin A, which inhibits the electron
ﬂow along the respiratory chain, proved to block oxygen consumption.
The respiratory control ratios (RCR) were calculated in either E GLU-WT
or E RAF-WT cells and expressed as the ratio between the rate of oxygen
consumption due to addition of the uncoupler CCCP and that in the ab-
sence of the uncoupler (Fig. 5B). They were 2 and 1.4, respectively. After
shift to pH 3.00 without acetic acid treatment (C), RCRs were 2.0 and
1.7 in GLU-WT and RAF-WT cells, respectively; mean RCR (±SD) values
were 1.8 (±0.2) and 1.4 (±0.2) in EGLU-WT and ERAF-WT cells, respec-
tively, versus 1.8 (±0.2) and 1.8 (±0.2) at pH 3.00. In parallel, we con-
ﬁrmed that RAF-WT cells show RTG pathway activation, as reported
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TMRM uptake) of exponential phase (OD600 = 0.6) GLU-WT and RAF-WT cells after shift to p
ﬂuorescence intensities, obtained by analysing monoparametric histograms of TMRM ﬂuoresc
of C GLU-WT and C RAF-WT cells at pH 3.00 was considered as 100 %. Cells were also treatedwi
of three independent experiments. (B)Oxygen consumptionwas continuouslymeasured inGLU
tangent to the progress traces, were constant, 1.25 μM CCCP was added and respiratory contro
Numbers along the traces are rate of oxygen uptake expressed as nmol O2 min−1 cell numb
cultures.3.4. Comparison of ROS production and cytochrome c release occurring in
AA-treated rafﬁnose- or glucose-grown cells
To gain aﬁrst insight into themechanismbywhichAA-PCD ismostly
prevented in RAF-WT cells by RTG pathway activation, but moderately
occurs in RAF-Δrtg2 cells, investigation of howAA-PCD takes place should
be necessary, as alreadymade inGLU-WT cells. To this aim,we investigat-
ed two yeast AA-PCD features, namely ROS production and cyt c release,
which represent an early (15 min) and late event (60–150 min), respec-
tively, en route to AA-PCD of GLU-WT cells [6]. ROS levels were analyzed
at 15 min AA-PCD by using H2DCF-DA [40,41] (Fig. 6). In GLU-WT cells,
as a result of AA-treatment a burst of ROS was observed at 15 min, with
about 67 % of DCF positive cells with a very low ROS level measured in
control cells. In RAF-WT at 15 min only about 22 % of DCF positive cells
was found whereas in RAF-Δrtg2 cells about 68 % of DCF-positive cells
were found.
Cyt c protein levels in both cytosolic and mitochondrial fractions
obtained from GLU-WT, RAF-WT and RAF-Δrtg2 cells added or not with
acetic acid were analyzed at 150 min by immunoblotting using anti-cyt
c antibody (Fig. 7). Anti-Pgk1p or anti-Ilv5p antibodies were also used
as cytosolic and mitochondrial matrix marker proteins respectively as in
[26]. No difference in the released cyt cwas observed in the cytosolic frac-
tion of both RAF-WT and RAF-Δrtg2 cells after AA-treatmentwith respect
to the same bands in the control cells as shown by densitometric analysis
(about a 60% increase in both cases) (Fig. 7A). Accordingly, a decrease in
mitochondrial cyt c content was observed after acetic acid treatment in
both RAF-WT and Δrtg2 cells but to a lesser extent (about 20 %) than in
the case of AA-PCD in GLU-WT (about 50%) (Fig. 7B). Notice that the re-
lease of cyt c into the cytosol of GLU-WT cells [26] was higher than in
the case of RAF-WT or RAF-Δrtg2 cells (150 % vs. 60 %).
4. Discussion
We show here that W303-1B yeast cells have a different sensitivity
to PCD induced in response to acetic acid dependent on the sugar
used as a sole carbon source for their growth. In this investigation useCells
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th 20 μMCCCP. 30,000 cells were analyzed per sample and the results are themean values
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er−1 from one representative experiment out of three experiments with different yeast
Fig. 6. Intracellular ROS levels inWT andΔrtg2 treatedwith acetic acid in rafﬁnose. RAF-WT
and RAF-Δrtg2 cells were incubated with H2DCF-DA in the absence (control) or in the pres-
ence of acetic acid for 15 min. Cells were collected and DCF-stained cells were detected by
confocal microscopy. Percentage of DCF-positive cells was calculated by analyzing at least
400 cells in three samples from each of three independent experiments. Student's t-test:
statistically signiﬁcantly different with (*) p b 0.0005 when comparing Δrtg2 with WT
AA-treated cells. YPD, white bars; YPR, black bars.
Fig. 7. Immunoblot analysis of the released cyt c. (A) Cytosolic and (B)mitochondrial frac-
tions fromWT and Δrtg2 cells treated with acetic acid (AA) or without acetic acid (C) in
rafﬁnose (RAF, black bars) for 150 min were analyzed by immunoblotting with anti-cyt
c antibody. As a control, the two fractions from AA-treated (AA-PCD) or control WT cells
in glucose (GLU, white bars) were similarly analyzed. The histograms report the cytosolic
andmitochondrial amounts of cyt c, quantiﬁed by densitometric scanning of theﬁlm, nor-
malizedwith antibodies against Pgk1p and Ilv5p, respectively, and expressed as a percent-
age of control cells, towhich a value of 100 has been given. Reported values are themeans
of triplicate measurements and representatives of at least three different experiments.
Student's t-test: statistically signiﬁcantly different with * p b 0.001, ** p b 0.01, when com-
paring subcellular fractions fromcells treatedwith acetic acid in rafﬁnosewith fractions from
WT cells treated with acetic acid in glucose.
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RAF-WT cells are mostly resistant to AA-PCD (Fig. 1); accordingly,
only in RAF-WT cells the activation of RTG pathway takes place in a
manner dependent on a variety of genes including RTG2, RTG3, MKS1.
HAP4, encoding the regulatory subunit of the Hap2,3,4,5 complex has
no role in this case (Figs. 1–4). In particular, we show that AA-PCD resis-
tance of RAF-WT cells occurs in amanner regulated by RTG2-dependent
phosphorylation state of Rtg3p, but it is also regulated by RTG2 itself (cfr
Figs. 1–3). Interestingly, we show that constitutive activation of RTG
pathway itself in GLU-Δmks1 cells does not result in AA-PCD resistance,
but that partial resistance to AA-PCD occurs when 0.5% GLU-WT cells
are used (Fig. 4). RTG pathway activation occurs in cells without appar-
ent mitochondrial dysfunction where coupled mitochondrial respira-
tion is still active (Fig. 5). Finally, we show that in yeast cells resistant
to AA-PCD both ROS accumulation (in an RTG2-sensitive manner) and
cyt c release, events which aremarkers of early and late AA-PCD respec-
tively, occur. These points will be dealt with separately.
RAF-WT cellswere foundmostly resistant to AA-PCDwith a simulta-
neous RTG pathway activation. That RTG pathway activation occurs
in RAF-WT cells is shown by the up-regulation of RTG-target genes,
i.e. CIT2 and IDH1. Such a conclusion is deﬁnitely conﬁrmed by the corre-
lation found betweenRTGpathway activation and i. the effects of deletion
of RTG pathway regulatory genes and ii. the Rtg3p phosphorylation
state. Use of yeast cells lacking RTG2 or RTG3, a positive regulator and
a transcription factor of the RTG pathway, respectively, shows that
lack of RTG pathway activation is accompanied by lack of AA-PCD
prevention. In fact, when either RTG2 or RTG3 is deleted, the conse-
quent failure in RTG pathway activation is accompanied by AA-PCD.
The change in the Rtg3p phosphorylation state dependent on RTG2 in
rafﬁnose-grown cells, treated with AA, shows that Rtg3p is regulated
by RTG2, but RTG2 itself is a contributor to AA-PCD resistance. Since par-
tial AA-PCD resistance is still found in RAF-Δrtg2 and RAF-Δrtg3 cells,
we are forced to assume that the change of yeast metabolism itself re-
sults in AA-PCD resistance in a manner independent on RTG pathway.
The explanation of how this can occur needs further investigation. On
the other hand, that the RTG pathway signiﬁcantly contributes, but is
not unique in determining AA-PCD resistance is shown by Fig. 4 inwhich the AA-PCD time courses of GLU-WT and in GLU-Δmks1 cells
are essentially indistinguishable. This shows that AA-PCD induction is
likely due to yeast metabolism under fermentative growth conditions
as occurring in GLU-WT cells; in glucose-grown cells no AA-PCD resis-
tance is possible even by constitutively activating RTG pathway, where-
as under condition in which yeast respiration occurs (RAF-cells) RTG
pathway activation contributes to AA-PCD resistance. Accordingly, the
role of yeast metabolism in AA-PCD resistance is also shown in 0.5%
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pression takes place, very low resistance to AA-PCD is found in 0.5%
GLU-WT cells. In 0.5% GLU-Δmks1 cells, an increase in AA-PCD re-
sistance is found due to AA-treatment; thus we could speculate
that the lack of glucose repression itself favours AA-PCD resistance
and it is a prerequisite for AA-stress resistance; yet another event is
necessary, likely due to yeast/mitochondrial metabolism, for a rather
complete AA-PCD resistance to occur. Such a hypothesis needs further
investigation.
Since the genes encoding mitochondrial citrate synthase, aconitase
and isocitrate dehydrogenase, switch between a dependence on
Rtg1/3p, in cells whose mitochondrial respiratory capacity is reduced,
and on Hap2,3,4,5p transcription complex in cells with robust mitochon-
drial function [34,42], we investigated the role of Hap2,3,4,5p transcrip-
tion complex in AA-PCD resistance. This is excluded having found that
both RAF-Δhap4 and RAF-Δrtg2Δhap4 cells do not differ from RAF-WT
and RAF-Δrtg2 with respect to AA-PCD resistance. Thus, other transcrip-
tion factors regulating glucose repressionmay be involved in AA-PCD re-
sistance of RAF-WT cells.
We show that an RTG transient activation takes place as a result of
cell pH shift to 3.00: the huge activation, about 200 % found immedi-
ately and up to 30 min after pH shift, decreases up to basal levels in
90-200 min time range. To date the RTG pathway activation is reported
as strictly related to the occurrence of mitochondrial dysfunction; to the
best of our knowledge we ﬁrst show that RTG pathway activation can
occur in yeast cells in which mitochondrial oxidative phosphorylation is
active: cells shifted to pH 3.00 still maintain coupled mitochondria with
RTG pathway activation. A ﬁrst indication derives from the TMRMexper-
iment which shows that both in GLU-WT and RAF-WT cells at pH 3.00
there is a cell population with coupled mitochondria exhibiting the
TMRM ﬂuorescence due to the probe binding to polarized mitochondrial
membrane and that as a result of the addition of the uncoupler CCCP such
a ﬂuorescence decreases by about 75%. Given that one could argue that
the ﬂuorescence signal might involve unspeciﬁc probe binding to some
cell membrane components [38,43] and since the experimental proce-
dure does not exclude changes in themitochondrial membrane potential
along time, we resorted to a simplemethod inwhich the respiratory con-
trol ratio is measured by continuous monitoring of the oxygen uptake of
the yeast cell suspensions. The point is that CCCP addition to cells grown
in either glucose- or rafﬁnose-medium shifted to pH 3.00, in which RTG
pathway is active, results in an increase of the rate of oxygen consump-
tion with a mean RCR equal to 1.8 in either cases, similar to that found
in the controls with no RTG pathway activation.
We show that en route to AA-PCD early ROS production in GLU-WT
[9,40,41] and in RAF-Δrtg2 cells was essentially unchanged, but it strong-
ly decreases in RAF-WT cells. This strongly suggests that in RAF-cells, ROS
production is largely under RTG2 control. Since in RAF-WT cells, which
aremostly resistant to AA-PCD, lower early ROS accumulation is detected
with respect to that found in GLU-WT and RAF-Δrtg2 undergoing
AA-PCD, we might assume that RTG pathway activation prevents
AA-PCD by decreasing early ROS level accumulation. Whether this de-
pends essentially on ROS production or increase in the scavenger sys-
tem, including superoxide dismutase and catalase [40] remains to be
established.Moreover, since RAF-Δrtg2 cells showpartial AA-PCD resis-
tance, we can conclude that ROS production itself is not sufﬁcient to
trigger complete AA-PCD in RAF-cells. However, in RAF-WT cells since
AA-PCD resistance is high, while ROS production is about 30% of that
in RAF-Δrtg2 cells, wemight speculate that, even if it is not a committed
step of AA-PCD, ROS level is too low thus preventing the processes nec-
essary for AA-PCD to occur, yet it remains high enough to allow for the
cyt c release. Thus in the light of Fig. 7, in which no difference in cyt c re-
lease occurs between RAF-WT and RAF-Δrtg2 cells, we have to assume
that relatively low ROS production is required to cause cyt c release.
In RAF-cells resistant toAA-PCD cyt c release occurs at a lower extent
with respect to that found in GLU-WT cells. However, given that the re-
lease of cyt c is essentially unchanged in resistant RAF-WT and partiallyresistant RAF-Δrtg2 cells, we conclude that other processes, different
from cyt c release, occur accounting for the different sensitivity to
AA-PCD. Perhaps differences in glucose and rafﬁnose yeast metabolism
account for differences in AA-PCD sensitivity. Thus AA-PCD resistance is
not due to a reduction in cyt c release. Different hypothesis could be
made to explain the role of cyt c release under condition in which
AA-PCD is mostly prevented. One of them is that in this case the role
of the released cyt c is similar to that already shown to occur en route
to AA-PCD in yeast and in cerebellar granule cells [26,44]: released cyt
c can work as a ROS scavenger and electron donor to the respiratory
chain. The initial experiments carried out essentially are in favour of
such a conclusion. On the other hand given that yeast AA-PCD can
occur also independently of cyt c release [8,9], this could be the case
for RAF-Δrtg2 cell AA-PCD. To gain further insight into this issue a de-
tailed investigation of AA-PCD process in RAF-Δrtg2 cells similar to
that carried out with GLU-WT cells is needed.
The current yeast RTG pathway scenario is that whatever mitochon-
drial dysfunction, including respiratory deﬁciency due tomtDNA deple-
tion (ρ°), antimycin A-dependent inhibition of the electron ﬂow along
the respiratory chain, CCCP-dependent uncoupling but not to the loss
ofmitochondrial ATP synthesis themselves can trigger the RTG pathway
[15], although ATP has been suggested as a candidate trigger of RTG sig-
nalling [45]. On the other hand, genetic evidence has also shown that
loss of mitochondrial membrane potential can trigger RTG pathway
extending replicative lifespan [46]. This paper shows for the ﬁrst time
that RTG pathway activation can occur also in yeast cells containing
coupled mitochondria.
Having shown that RTG pathway activation contributes to AA-PCD
resistance a question arises as to the other contributors to AA-PCD resis-
tance. Another candidate signalling pathway could be that dependent
on Hog1 stress-activated protein kinase, which is essential for the in-
duction of diverse osmoadaptive responses in yeast and can control
the Rtg1/3p transcriptional complex [47] and acetic-acid stress adapta-
tion [48]. Interestingly enough, RTG-target gene expression can also be
activated by exposure of cells to rapamycin, an inhibitor of the target of
rapamycin (TOR) kinase signalling pathway that is involved in a broad
range of cellular activities, including growth control, nutrient sensing
and longevity [49]. This paper shows that RTG pathway activation de-
creases AA-PCD rate, which is in agreement with the possible role of
TOR in causing AA-PCD [50] even though retrograde gene expression
is separable from TOR regulation of RTG-responsive genes [51]. The
RTGpathway can regulate factor/s involved in AA-PCD that is/are absent
or inactive in RAF-Δrtg2 cells. Indeed, RTG2 deletion could affect
pathways different from the RTG pathway and could have opposite
effect on the AA-PCD process. Indeed RTG2 has been shown to exert
its function in the epigenetic regulation of gene expression [52] and
the mitochondria-vacuole cross-talk [32]. Another possible process in-
volved in rafﬁnose-grown yeast AA-PCD resistance is mitophagy, a pro-
cess in which mitochondria are selectively removed by autophagy
allowing cell adaptation to changing metabolic needs [53,54]. Indeed,
RTG signalling has been shown to be important for mitophagy: AUP1,
encoding a protein phosphatase localized in the mitochondrial inter-
membrane space, is required for efﬁcient stationary phase mitophagy
and RTG pathway activation through regulation of Rtg3p phosphoryla-
tion [55].5. Conclusion
Here we give ﬁrst experimental evidence of the contribution of the
mitochondrial RTG-dependent retrograde response in determining re-
sistance to yeast PCD. It is interesting to note that resistance to cell
death is one of the hallmarks of cancer [56] and that mitochondria-
to-nucleus retrograde response has been involved in tumorigenesis
[57–59]. Our results, together with the role of RTG pathway in
extending replicative life span in yeast [60] make yeast an attractive
2773N. Guaragnella et al. / Biochimica et Biophysica Acta 1833 (2013) 2765–2774model to investigate the relations between PCD and mitochondrial
dysfunction in both physiological and pathological conditions [61,62].
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